LOADING
Comparing Broadcom Inc (AVGO) and Pfizer Inc (PFE) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | AVGO | PFE |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $1.81T | $142.9B |
| P/E Ratio | 65.3 | 19.1 |
| Forward P/E | 33.9 | 8.5 |
| PEG Ratio | 0.71 | 3.77 |
| EPS | $5.82 | $1.31 |
| Revenue Growth (YoY) | 47.9% | 5.4% |
| Profit Margin | 38.9% | 11.8% |
| Return on Equity | 37.3% | 8.3% |
| Dividend Yield | 0.65% | 6.82% |
| Beta | 1.43 | 0.29 |
| 52-Week High | $494.18 | $28.28 |
| 52-Week Low | $260.73 | $21.97 |
| Volume | -- | -- |
Broadcom Inc is the larger company by market capitalization. Pfizer Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Broadcom Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.